| Literature DB >> 30255304 |
J Sperzel1,2, C Hamm3, A Hain3.
Abstract
Leadless self-contained intracardiac pacemakers were developed with the aim of abolishing the short- and long-term risk of lead- and pocket-related complications associated with transvenous devices. Leadless pacemakers promise minimally invasive procedures, long battery lives, and small amounts of foreign materials in the body. Experiences with the pioneering single-chamber devices have provided reasons for optimism about the future of the leadless concept. In the future, as more patients receive and live longer with implantable devices, the total risk of procedure- and lead-related complications is expected to increase, adding a sense of urgency to the need for leadless alternatives to transvenous pacemakers. This review surveys the performance of currently available leadless pacemakers as well as emerging new innovative adaptations and applications of the leadless concept.Entities:
Keywords: Cardiac resynchronization therapy; Dual-chamber pacing; Implantable cardioverter-defibrillator; Pacemaker; Single-chamber pacing
Mesh:
Year: 2018 PMID: 30255304 DOI: 10.1007/s00059-018-4752-9
Source DB: PubMed Journal: Herz ISSN: 0340-9937 Impact factor: 1.443